Health Economics & Outcomes Research
We generate health economic and outcomes evidence that demonstrates value, measures impact, and informs decision-making.
How We Build Payer-Ready Evidence
We approach HEOR as a decision-support discipline, not just an analytical exercise. Our work begins with the questions payers and HTA bodies ask - around disease burden, comparative value, cost-effectiveness, budget impact, and patient access.
From there, we define the right evidence strategy, identify fit-for-purpose clinical, real-world, and economic data, and apply robust methods to generate payer-relevant insights. Every model, analysis, and evidence package is designed to support value demonstration, reimbursement, and market access decisions.
By aligning HEOR strategy to stakeholder expectations from the start, we help organizations translate evidence into clear, credible value stories.
Core Elements of Our Approach
End-to-End HEOR Capabilities
We design and deliver HEOR capabilities that help organizations demonstrate value, support reimbursement, and inform payer and HTA decisions.
HEOR Strategy & Planning
- Define evidence strategy, Value frameworks, Stakeholder priorities for reimbursement and access
Economic Modelling
- Build cost-effectiveness, Budget impact, Disease burden, Sensitivity models for value demonstration
Evidence Synthesis
- Generate comparative and contextual evidence through systematic reviews, Meta-analyses, Indirect comparisons
Outcomes & Real-World Evidence
- Develop patient-centered and real-world evidence that strengthens outcomes assessment and payer relevance
HTA & Value Dossiers
- Prepare HTA-ready evidence packages, Global value dossiers, Payer-facing submissions
Market Access & Pricing Support
- Prepare HTA-ready evidence packages, Global value dossiers, Payer-facing submissions
From Value Question to Access Decision
A structured framework for building value evidence that supports HTA, reimbursement, and market access decisions.
Value Question
Define the payer or HTA decision to support.
Evidence Strategy
Select the right data and evidence plan.
Comparative & Outcomes Evidence
Build the value story with burden and outcomes evidence.
Economic Modelling
Quantify value through robust HEOR models.
HTA & Value Dossiers
Prepare payer-ready evidence packages.
Access Decision Support
Enable reimbursement and market access action.
IQA Solutions & Technology for HEOR
Our HEOR programs are strengthened by purpose-built IQA solutions and industry-standard analytical technologies that support evidence generation, economic modelling, HTA intelligence, reproducible workflows, and submission-ready outputs.
IQA Solutions
Analytical & Modelling Technologies
End-to-End HEOR Execution
From evidence strategy and economic modelling through dossiers, HTA submissions, and market access support, we build connected HEOR programs that carry a coherent value story from planning to decision.
Payer-Question-Led Evidence Design
Our work begins with the questions payers and HTA bodies actually ask - around burden, comparative value, cost-effectiveness, budget impact, and utilization - so evidence is built for decision-making, not retrofitted later.
Global HTA Readiness
We prepare and adapt evidence packages for the methodological expectations of major HTA bodies and payer markets, helping organizations align value communication to local decision frameworks .
Technology-Enabled HEOR Delivery
Our HEOR programs are strengthened by IQA solutions that support evidence management,modelling workflows, HTA intelligence, traceability, and submission-ready outputs.
Decision-Ready Models and Evidence
We develop transparent, reusable, and market-adaptable models and evidence packages that support value demonstration, reimbursement discussions, and access strategy.
Reimbursement Isn't Given. It's Earned
Tell us your indication, your HTA targets and your biggest evidence gap. We'll map the path from where you are to where your therapy needs to be - with a model and dossier strategy built to win.